Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Saskatchewan

$30,360.00

Molecular & cellular response to gonadotropins in superovulation

EF 2006-07

Résumé
Hormone-induced ovarian stimulation, also termed superovulation, is an essential procedure for in vitro fertilization (IVF), embryo transfer, and other assisted reproductive technologies.  The methodology for ovarian stimulation in domestic animals has been available for many years.  However, the unpredictable ovarian response, in terms of viable eggs and embryo quality, are still the main factors limiting the success of assisted reproductive technology programs.  These problems have direct economic implications, since export of Canadian embryos, and pharmaceutical products for use in animal reproduction, amounts to several million dollars per year.  The current techniques for superovulation rely on the administration of an external source of gonadotropins including follicle stimulating hormone (FSH), and luteinizing hormone (LH).  Gonadotropins bind to cell-surface receptors of the developing follicle, and mediate biological activities through signal transduction pathways leading to cell proliferation and follicular growth.  A more recent approach to stimulate the ovaries involves the pharmacological inhibition of the phosphodiesterases (PDEs), the enzymes that inactivate the intracellular messenger that mediates the effects of the gonadotropins.  We propose that recombinant gonadotropins of very high potency (superagonists), combined with pharmacological inhibition of the PDEs, will represent a novel method to induce superovulation.  We aim to develop strategies to reduce the frequency of gonadotropin injection in order to lower the handling stress on the prospective donor and decrease the labour costs.  Reducing the amount of gonadotropins is advantageous because high levels are associated with a reduction in oocyte and embryo quality.  Therefore, we will synthesize recombinant agonists of the gonadotropins and characterize their responses in the ovary in combination with the PDE inhibitors.  By characterizing molecular and cellular responses to gonadotropins we will identify novel targets for pharmacological interventions in the ovary.  The emerging information will lead to the development of better methods of superovulation and improved rates of success in the application of assisted reproductive technologies to farmed game and domestic animals.
Programme
Discovery Grants Program - Individual
Emplacement
Saskatchewan, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
155506-2006
Name nom
Chedrese, Jorge
Department département
Obstetrics, Gynecology and Reproductive Sciences
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2006
Competition year année de concours
2006
Award amount
30360
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1011
Committee name en
Integrative Animal Biology
Committee name fr
Biologie Animale Intégrative
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5505
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal reproduction
Research subject fr
Reproduction animale
Partie
1
Nb partie
5
Application title
Molecular & cellular response to gonadotropins in superovulation
Keyword
NA
Application summary
Hormone-induced ovarian stimulation, also termed superovulation, is an essential procedure for in vitro fertilization (IVF), embryo transfer, and other assisted reproductive technologies.  The methodology for ovarian stimulation in domestic animals has been available for many years.  However, the unpredictable ovarian response, in terms of viable eggs and embryo quality, are still the main factors limiting the success of assisted reproductive technology programs.  These problems have direct economic implications, since export of Canadian embryos, and pharmaceutical products for use in animal reproduction, amounts to several million dollars per year.  The current techniques for superovulation rely on the administration of an external source of gonadotropins including follicle stimulating hormone (FSH), and luteinizing hormone (LH).  Gonadotropins bind to cell-surface receptors of the developing follicle, and mediate biological activities through signal transduction pathways leading to cell proliferation and follicular growth.  A more recent approach to stimulate the ovaries involves the pharmacological inhibition of the phosphodiesterases (PDEs), the enzymes that inactivate the intracellular messenger that mediates the effects of the gonadotropins.  We propose that recombinant gonadotropins of very high potency (superagonists), combined with pharmacological inhibition of the PDEs, will represent a novel method to induce superovulation.  We aim to develop strategies to reduce the frequency of gonadotropin injection in order to lower the handling stress on the prospective donor and decrease the labour costs.  Reducing the amount of gonadotropins is advantageous because high levels are associated with a reduction in oocyte and embryo quality.  Therefore, we will synthesize recombinant agonists of the gonadotropins and characterize their responses in the ovary in combination with the PDE inhibitors.  By characterizing molecular and cellular responses to gonadotropins we will identify novel targets for pharmacological interventions in the ovary.  The emerging information will lead to the development of better methods of superovulation and improved rates of success in the application of assisted reproductive technologies to farmed game and domestic animals.